Monopar Therapeutics Stock Technical Analysis
| MNPR Stock | USD 20.10 0.39 1.98% |
As of the 25th of November, Monopar Therapeutics secures the Mean Deviation of 20.56, downside deviation of 11.06, and Risk Adjusted Performance of 0.1111. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Monopar Therapeutics, as well as the relationship between them. Please verify Monopar Therapeutics standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Monopar Therapeutics is priced some-what accurately, providing market reflects its recent price of 20.1 per share. Given that Monopar Therapeutics has jensen alpha of 10.46, we recommend you to check Monopar Therapeutics's last-minute market performance to make sure the company can sustain itself at a future point.
Monopar Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Monopar, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MonoparMonopar |
Monopar Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 8.5 | Strong Buy | 3 | Odds |
Most Monopar analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Monopar stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Monopar Therapeutics, talking to its executives and customers, or listening to Monopar conference calls.
Monopar Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Monopar Therapeutics Technical Analysis
The output start index for this execution was twelve with a total number of output elements of fourty-nine. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Monopar Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Monopar Therapeutics Trend Analysis
Use this graph to draw trend lines for Monopar Therapeutics. You can use it to identify possible trend reversals for Monopar Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Monopar Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Monopar Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Monopar Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.34 , which means Monopar Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 4268.14, which is the sum of squared deviations for the predicted Monopar Therapeutics price change compared to its average price change.About Monopar Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Monopar Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Monopar Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Monopar Therapeutics price pattern first instead of the macroeconomic environment surrounding Monopar Therapeutics. By analyzing Monopar Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Monopar Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Monopar Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
Monopar Therapeutics November 25, 2024 Technical Indicators
Most technical analysis of Monopar help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Monopar from various momentum indicators to cycle indicators. When you analyze Monopar charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1111 | |||
| Market Risk Adjusted Performance | (2.30) | |||
| Mean Deviation | 20.56 | |||
| Semi Deviation | 7.9 | |||
| Downside Deviation | 11.06 | |||
| Coefficient Of Variation | 757.81 | |||
| Standard Deviation | 75.41 | |||
| Variance | 5686.35 | |||
| Information Ratio | 0.1302 | |||
| Jensen Alpha | 10.46 | |||
| Total Risk Alpha | (1.93) | |||
| Sortino Ratio | 0.8882 | |||
| Treynor Ratio | (2.31) | |||
| Maximum Drawdown | 653.56 | |||
| Value At Risk | (9.50) | |||
| Potential Upside | 15.93 | |||
| Downside Variance | 122.25 | |||
| Semi Variance | 62.35 | |||
| Expected Short fall | (25.58) | |||
| Skewness | 7.8 | |||
| Kurtosis | 62.47 |
Additional Tools for Monopar Stock Analysis
When running Monopar Therapeutics' price analysis, check to measure Monopar Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Monopar Therapeutics is operating at the current time. Most of Monopar Therapeutics' value examination focuses on studying past and present price action to predict the probability of Monopar Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Monopar Therapeutics' price. Additionally, you may evaluate how the addition of Monopar Therapeutics to your portfolios can decrease your overall portfolio volatility.